AbbVie, Inc.
Brak transakcji
Korporacyjne papiery dłużne
Poniżej znajduje się lista obligacji AbbVie, Inc., posortowana według rentowności do wykupu. Inwestorzy często wybierają obligacje spółek ze względu na ich większą stabilność w okresach zmienności rynkowej. Przeanalizuj ceny, rentowności oraz inne statystyki i znajdź wiarygodną inwestycję.
Symbol | YTM % | Wolumen | Cena % | Kupon % | Termin zapadalności | Kwota niezapłacona | Wartość nominalna | Min. kw. nominału | Emitent |
|---|---|---|---|---|---|---|---|---|---|
| AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045 | 7,00% | 26 K | 76,04% | 4,750% | 2045-03-15 | 53,51 M USD | 1 000,00 USD | 2 000,00 USD | Allergan Funding SCS |
| AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044 | 6,40% | 12 K | 83,25% | 4,850% | 2044-06-15 | 65,23 M USD | 1 000,00 USD | 2 000,00 USD | Allergan Funding SCS |
| AACT3910526Actavis, Inc. 4.625% 01-OCT-2042 | 6,38% | 124 K | 81,98% | 4,625% | 2042-10-01 | 67,49 M USD | 1 000,00 USD | 2 000,00 USD | Actavis, Inc. |
| AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035 | 5,79% | 250 K | 91,22% | 4,550% | 2035-03-15 | 107,65 M USD | 1 000,00 USD | 2 000,00 USD | Allergan Funding SCS |
| 5,70% | 2,21 M | 96,77% | 5,500% | 2064-03-15 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 5,62% | 24,81 M | 97,08% | 5,400% | 2054-03-15 | 3 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 5,59% | 7,57 M | 100,14% | 5,600% | 2055-03-15 | 750 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 5,57% | 0 | 86,46% | 4,450% | 2046-05-14 | 2 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 5,56% | 3,38 M | 82,72% | 4,250% | 2049-11-21 | 5,75 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 5,55% | 12,2 M | 91,10% | 4,875% | 2048-11-14 | 1,75 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 5,54% | 0 | 90,09% | 4,700% | 2045-05-14 | 2,7 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 5,49% | 26 K | 90,47% | 3,200% | 2029-11-21 | 62,52 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 5,48% | 65 K | 91,35% | 4,750% | 2045-03-15 | 827,09 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 5,48% | 2,53 M | 92,76% | 4,850% | 2044-06-15 | 1,01 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 5,45% | 3,9 M | 99,00% | 5,350% | 2044-03-15 | 750 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 5,40% | 376 K | 91,68% | 4,625% | 2042-10-01 | 389,22 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 5,38% | 0 | 89,18% | 4,400% | 2042-11-06 | 2,6 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 5,14% | 3,45 M | 89,24% | 4,050% | 2039-11-21 | 4 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 4,86% | 0 | 95,47% | 4,300% | 2036-05-14 | 1 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 4,78% | 0 | 97,89% | 4,500% | 2035-05-14 | 2,5 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 4,74% | 4,42 M | 103,42% | 5,200% | 2035-03-15 | 1 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 4,73% | 14,19 M | 98,65% | 4,550% | 2035-03-15 | 1,68 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 4,63% | 5,54 M | 102,83% | 5,050% | 2034-03-15 | 3 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 4,18% | 3,13 M | 103,48% | 4,950% | 2031-03-15 | 2 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 4,06% | 8,01 M | 97,24% | 3,200% | 2029-11-21 | 5,44 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 4,04% | 1,41 M | 103,20% | 4,875% | 2030-03-15 | 1 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 3,93% | 0 | 99,81% | 3,200% | 2026-05-14 | 2 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 3,90% | 3,63 M | 102,64% | 4,800% | 2029-03-15 | 2,5 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 3,79% | 9,89 M | 101,16% | 4,250% | 2028-11-14 | 1,75 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 3,78% | 1,12 M | 101,14% | 4,800% | 2027-03-15 | 2,25 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 3,76% | 411 K | 101,79% | 4,650% | 2028-03-15 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 3,75% | 12,79 M | 99,37% | 2,950% | 2026-11-21 | 3,99 B USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| XXS162262122Allergan Funding SCS 2.125% 01-JUN-2029 | 3,64% | 0 | 95,34% | 2,125% | 2029-06-01 | 36,46 M EUR | 1 000,00 EUR | 100 000,00 EUR | Allergan Funding SCS |
| 3,62% | 0 | 97,43% | 2,625% | 2028-11-15 | 72,11 M EUR | 1 000,00 EUR | 100 000,00 EUR | Allergan Funding SCS | |
| 3,16% | 0 | 126,76% | 4,750% | 2045-03-15 | 5 K USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 3,13% | 0 | 128,71% | 4,850% | 2044-06-15 | 100 K USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 3,13% | 0 | 121,31% | 4,250% | 2049-11-21 | 4,95 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 2,97% | 0 | 90,95% | 1,250% | 2031-11-18 | 650 M EUR | 1 000,00 EUR | 100 000,00 EUR | AbbVie, Inc. | |
| 2,60% | 0 | 98,51% | 2,125% | 2029-06-01 | 506,09 M EUR | 1 000,00 EUR | 100 000,00 EUR | AbbVie, Inc. | |
| 2,57% | 0 | 123,74% | 4,550% | 2035-03-15 | 1 K USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| 2,53% | 0 | 98,91% | 2,125% | 2028-11-17 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | AbbVie, Inc. | |
| 2,50% | 0 | 100,33% | 2,625% | 2028-11-15 | 427,79 M EUR | 1 000,00 EUR | 100 000,00 EUR | AbbVie, Inc. | |
| 2,39% | 0 | 97,17% | 0,750% | 2027-11-18 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | AbbVie, Inc. | |
| −5,92% | 0 | 98,80% | 2,950% | 2026-11-21 | 9,24 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. | |
| — | — | — | 4,400% | 2042-11-06 | 1,1 M USD | 1 000,00 USD | 2 000,00 USD | AbbVie, Inc. |